23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › MAXCYTE INC. › 2023-2024

MAXCYTE INC. 2023-2024 Proxy Voting Records

At MAXCYTE INC.'s shareholder meeting held June 11, 2024, in the 2023-2024 proxy season, 52 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 746 separate fund positions. On the most widely held item on that ballot — To approve an amendment to the MaxCyte, Inc. 2022 Equity Incentive Plan to increase the shares… — FOR was 85% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: MAXCYTE INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2024.

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and MAXCYTE INC.’s Form 8-K, filed June 12, 2024 (Item 5.07 on EDGAR). Page generated November 8, 2026.

  • 5Ballot items
  • 52Asset managers
  • 746Fund votes
  • June 11, 2024Meeting date

Results at a glance

Meeting of June 11, 2024: 5 items on MAXCYTE INC.’s Form 8-K, filed June 12, 2024: 5 without a stated outcome.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024

Explore MAXCYTE INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by MAXCYTE INC.

These tallies are MAXCYTE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

MAXCYTE INC. — official shareholder meeting results, meeting held June 11, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Will Brooke 68,727,229---- 1,026,17012,060,733 99%Not verified—
Elect Director: John Johnston 68,991,928---- 761,47112,060,733 99%Not verified—
Elect Director: Richard Douglas 48,055,363---- 21,698,03612,060,733 69%Not verified—
2. Approval of the Plan Amendment 58,665,61810,758,144329,637 --12,060,733 85%Not verified—
3. Ratification of appointment of CohnReznick LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024 81,711,9237,32794,882 ---- 99.9%Not verified—

Source: MAXCYTE INC., Form 8-K, filed with the SEC on June 12, 2024 — read the filing on EDGAR.

How asset managers voted at the MAXCYTE INC. 2023-2024 meeting

Each item below shows how the 52 asset managers that disclosed a MAXCYTE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: John Johnston

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 68,991,928WITHHELD: 761,471
Details: description as filed, official tally, votes by 49 asset managers

Description as filed by funds: Election of Class III Directors: John Johnston

MAXCYTE INC.’s own tally for this item (“Elect Director: John Johnston”): 68,991,928 for, 761,471 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 22,246,445 for, 324,142 withheld, 27,693 abstained.

FOR
FOR: 22,246,445ABSTAIN: 27,693WITHHOLD: 324,142
Largest asset managers voting on “Election of Class III Directors: John Johnston” at MAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,921,8490 00For
Vanguard5,202,0780 00For
BlackRock3,877,0640 00For
MFS2,169,4170 00For
Columbia Threadneedle1,052,8470 00For
Morgan Stanley1,034,1020 00For
Pacific Life423,1680 00For
Equitable370,7100 00For
Dimensional00 0307,760Withhold
MERIDIAN FUND INC265,7770 00For
Charles Schwab242,8920 00For
ALGER FUNDS188,7440 00For
QUANTITATIVE MASTER SERIES LLC160,4800 00For
ALGER PORTFOLIOS135,5760 00For
American Century132,5450 00For
TIAA127,4710 00For
SEI115,0080 00For
Allspring109,6410 00For
Royce100,5560 00For
Lincoln Financial75,2000 00For
ALGER INSTITUTIONAL FUNDS73,3080 00For
Prudential/PGIM61,4940 00For
Grandeur Peak Global Trust47,0620 00For
AIG/SunAmerica43,0710 00For
Northern Trust39,1140 00For

Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).

2. Elect Director: Richard Douglas

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

69% Majority: yes · of votes cast

FOR 69%WITHHELD
FOR: 48,055,363WITHHELD: 21,698,036
Details: description as filed, official tally, votes by 49 asset managers

Description as filed by funds: Election of Class III Directors: Richard Douglas

MAXCYTE INC.’s own tally for this item (“Elect Director: Richard Douglas”): 48,055,363 for, 21,698,036 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 69% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 12,624,724 for, 9,878,028 withheld, 95,528 abstained.

FORWITHHOLD
FOR: 12,624,724ABSTAIN: 95,528WITHHOLD: 9,878,028
Largest asset managers voting on “Election of Class III Directors: Richard Douglas” at MAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,072,4310 0849,418Mixed
Vanguard5,202,0780 00For
BlackRock00 03,877,064Withhold
MFS00 02,169,417Withhold
Columbia Threadneedle00 01,052,847Withhold
Morgan Stanley1,030,8730 03,229For
Pacific Life201,8000 0221,368Mixed
Equitable283,7930 086,917Mixed
Dimensional00 0307,760Withhold
MERIDIAN FUND INC265,7770 00For
Charles Schwab242,8920 00For
ALGER FUNDS00 0188,744Withhold
QUANTITATIVE MASTER SERIES LLC00 0160,480Withhold
ALGER PORTFOLIOS00 0135,576Withhold
American Century00 0132,545Withhold
TIAA00 0127,471Withhold
SEI115,0080 00For
Allspring00 0109,641Withhold
Royce100,5560 00For
Lincoln Financial00 075,200Withhold
ALGER INSTITUTIONAL FUNDS00 073,308Withhold
Prudential/PGIM00 061,494Withhold
Grandeur Peak Global Trust47,0620 00For
AIG/SunAmerica00 043,071Withhold
Northern Trust00 039,114Withhold

Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).

3. Elect Director: Will Brooke

Outcome not verifiedDIRECTOR ELECTIONSReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 68,727,229WITHHELD: 1,026,170
Details: description as filed, official tally, votes by 49 asset managers

Description as filed by funds: Election of Class III Directors: Will Brooke

MAXCYTE INC.’s own tally for this item (“Elect Director: Will Brooke”): 68,727,229 for, 1,026,170 withheld, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 49 asset managers below reported 22,176,775 for, 393,812 withheld, 27,693 abstained.

FOR
FOR: 22,176,775ABSTAIN: 27,693WITHHOLD: 393,812
Largest asset managers voting on “Election of Class III Directors: Will Brooke” at MAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,921,8490 00For
Vanguard5,202,0780 00For
BlackRock3,877,0640 00For
MFS2,169,4170 00For
Columbia Threadneedle1,052,8470 00For
Morgan Stanley1,034,1020 00For
Pacific Life423,1680 00For
Equitable301,0400 069,670Mixed
Dimensional00 0307,760Withhold
MERIDIAN FUND INC265,7770 00For
Charles Schwab242,8920 00For
ALGER FUNDS188,7440 00For
QUANTITATIVE MASTER SERIES LLC160,4800 00For
ALGER PORTFOLIOS135,5760 00For
American Century132,5450 00For
TIAA127,4710 00For
SEI115,0080 00For
Allspring109,6410 00For
Royce100,5560 00For
Lincoln Financial75,2000 00For
ALGER INSTITUTIONAL FUNDS73,3080 00For
Prudential/PGIM61,4940 00For
Grandeur Peak Global Trust47,0620 00For
AIG/SunAmerica43,0710 00For
Northern Trust39,1140 00For

Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).

4. Approval of the Plan Amendment

Outcome not verifiedFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 58,665,618AGAINST: 10,758,144
Details: description as filed, official tally, votes by 52 asset managers

Description as filed by funds: To approve an amendment to the MaxCyte, Inc. 2022 Equity Incentive Plan to increase the shares available for issuance.

MAXCYTE INC.’s own tally for this item (“2. Approval of the Plan Amendment”): 58,665,618 for, 10,758,144 against, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 49 asset managers voting on “To approve an amendment to the MaxCyte, Inc. 2022 Equity Incentive Plan to increase the shares available for i” at MAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,921,8490 00For
Vanguard5,202,0780 00For
BlackRock3,877,0640 00For
MFS02,169,417 00Against
Columbia Threadneedle01,052,847 00Against
Morgan Stanley1,034,1020 00For
Pacific Life235,738187,430 00Mixed
Equitable370,7100 00For
Dimensional307,7600 00For
MERIDIAN FUND INC265,7770 00For
Charles Schwab242,8920 00For
ALGER FUNDS188,7440 00For
QUANTITATIVE MASTER SERIES LLC160,4800 00For
ALGER PORTFOLIOS135,5760 00For
American Century0132,545 00Against
TIAA127,4710 00For
SEI115,0080 00For
Allspring109,6410 00For
Royce100,5560 00For
Lincoln Financial075,200 00Against
ALGER INSTITUTIONAL FUNDS73,3080 00For
Prudential/PGIM061,494 00Against
Grandeur Peak Global Trust47,0620 00For
AIG/SunAmerica43,0710 00For
Northern Trust39,1140 00For

Fund voting reports, all 49 managers: 18,877,263 for, 3,704,635 against, 16,382 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 2 asset managers voting on “To approve an amendment to the MaxCyte, Inc. 2022 Equity Incentive Plan to increase the shares available for i” at MAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Blue Water Life Science Advisors, LP0603,937 00Against
ALGERT GLOBAL LLC28,1850 00For

Institutional-manager reports, all 2 managers: 28,185 for, 603,937 against.

5. Ratification of appointment of CohnReznick LLP as independent registered public accounting firm of the Company for its…

Outcome not verifiedAUDIT-RELATEDReported outcome: Not verified

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 81,711,923AGAINST: 7,327
Details: description as filed, official tally, votes by 44 asset managers

Description as filed by funds: To ratify the selection by the Audit Committee of the Board of Directors of CohnReznick LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024.

MAXCYTE INC.’s own tally for this item (“3. Ratification of appointment of CohnReznick LLP as independent registered public accounting firm of the Company for its fiscal year ending December 31, 2024”): 81,711,923 for, 7,327 against, per its Form 8-K filed June 12, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 44 asset managers below reported 21,950,284 for.

FOR
FOR: 21,950,284
Largest asset managers voting on “To ratify the selection by the Audit Committee of the Board of Directors of CohnReznick LLP as the independent” at MAXCYTE INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Fidelity5,921,8490 00For
Vanguard5,202,0780 00For
BlackRock3,877,0640 00For
MFS2,169,4170 00For
Columbia Threadneedle1,052,8470 00For
Morgan Stanley1,034,1020 00For
Pacific Life423,1680 00For
Equitable370,7100 00For
Dimensional307,7600 00For
ALGER FUNDS188,7440 00For
QUANTITATIVE MASTER SERIES LLC160,4800 00For
ALGER PORTFOLIOS135,5760 00For
American Century132,5450 00For
TIAA127,4710 00For
Allspring109,6410 00For
Royce100,5560 00For
Lincoln Financial75,2000 00For
ALGER INSTITUTIONAL FUNDS73,3080 00For
Prudential/PGIM61,4940 00For
Grandeur Peak Global Trust47,0620 00For
AIG/SunAmerica43,0710 00For
Northern Trust39,1140 00For
John Hancock37,5340 00For
Bridge Builder Trust34,0000 00For
Guardian Variable Products Trust30,3880 00For

Showing the 25 largest of 44 asset managers. All 44 are in the interactive database (link above).

Largest MAXCYTE INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 104,544,289 shares outstanding at the time of that meeting.

Fund voting reports: top MAXCYTE INC. shareholders by shares voted on “To approve an amendment to the MaxCyte, Inc. 2022 Equity Incentive Plan to increase the shares…”, 2023-2024
#Asset manager % of shares outstanding
1Fidelity 5.66%
2Vanguard 4.98%
3BlackRock 3.71%
4MFS 2.08%
5Columbia Threadneedle 1.01%
6Morgan Stanley 0.99%
7Pacific Life 0.40%
8Equitable 0.35%
9Dimensional 0.29%
10MERIDIAN FUND INC 0.25%
Institutional-manager reports: top MAXCYTE INC. shareholders by shares voted on “To approve an amendment to the MaxCyte, Inc. 2022 Equity Incentive Plan to increase the shares…”, 2023-2024
#Asset manager % of shares outstanding
1Blue Water Life Science Advisors, LP 0.58%
2ALGERT GLOBAL LLC 0.03%

Reported MAXCYTE INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

MAXCYTE INC. holdings and ownership disclosed for the 2023-2024 proxy season
Holder % outstanding Disclosure
BlackRock 9.55% 13F
Cadian Capital Management, LP 8.94% 13G
Morgan Stanley 6.40% 13F
Millennium Management 5.90% 13F
Integrated Core Strategies (US) LLC 5.50% DEF14A
Vanguard Group 5.35% 13F
Doug Doerfler 2.68% DEF14A
Geode Capital 2.04% 13F
State Street 1.90% 13F
Dimensional Fund Advisors 0.85% 13F

Percentages above are of 104,544,289 shares outstanding, as reported by MAXCYTE INC. on its Form 10-Q dated May 2, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from MAXCYTE INC.’s 10-Q dated May 2, 2024. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.

MAXCYTE INC. proxy season coverage: 2023-2024 (this page).

Cite this page

proxyvotesnow.com, “MAXCYTE (MXCT) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/maxcyte-inc/2024 (version of November 9, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.